- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/04 - Amoebicides
Patent holdings for IPC class A61P 33/04
Total number of patents in this class: 74
10-year publication summary
3
|
5
|
1
|
4
|
2
|
1
|
10
|
6
|
5
|
7
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
CJ Cheiljedang Corporation | 3427 |
5 |
Nihon Nohyaku Co., Ltd. | 327 |
4 |
The University of Tokyo | 4193 |
4 |
Nutreco IP Assets B.V. | 176 |
3 |
Access to Advanced Health Institute | 76 |
3 |
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 185 |
2 |
Laboratorios Senosiain S.A. de C.V. | 19 |
2 |
Santen Pharmaceutical Co., Ltd. | 599 |
2 |
University of The West of Scotland | 17 |
2 |
Profounda Health and Beauty Inc. | 18 |
2 |
Massachusetts Institute of Technology | 10066 |
1 |
Wisconsin Alumni Research Foundation | 3889 |
1 |
University of South Florida | 1835 |
1 |
The Australian National University | 192 |
1 |
Clemson University | 182 |
1 |
Commonwealth Scientific and Industrial Research Organisation | 1658 |
1 |
Georgia State University Research Foundation, Inc. | 348 |
1 |
H Sulphur Corp. | 8 |
1 |
Industry-Academic Cooperation Foundation Gyeongsang National University | 586 |
1 |
Kyoto University | 2803 |
1 |
Other owners | 35 |